Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Schwaederle

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Oncotarget|August 7, 2015
Genomic landscape of salivary gland tumorsShumei Kato, Sheryl K Elkin, Maria Schwaederle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2015
Impact of Precision Medicine in Diverse Cancers: A Meta-Analysis of Phase II Clinical TrialsMaria Schwaederle, Melissa Zhao, J Jack Lee, et al.
JAMA Oncology|June 9, 2016
Association of Biomarker-Based Treatment Strategies With Response Rates and Progression-Free Survival in Refractory Malignant Neoplasms: A Meta-analysisMaria Schwaederle, Melissa Zhao, J Jack Lee, et al.
Molecular Cancer Therapeutics|May 20, 2016
Cell-Cycle Gene Alterations in 4,864 Tumors Analyzed by Next-Generation Sequencing: Implications for Targeted TherapeuticsTeresa Helsten, Shumei Kato, Maria Schwaederle, et al.
Molecular Cancer Therapeutics|April 9, 2015
On the Road to Precision Cancer Medicine: Analysis of Genomic Biomarker Actionability in 439 PatientsMaria Schwaederle, Gregory A Daniels, David E Piccioni, et al.
Cell Cycle (Georgetown, Tex.)|February 20, 2015
Cyclin-dependent kinase pathway aberrations in diverse malignancies: clinical and molecular characteristicsShumei Kato, Maria Schwaederle, Gregory A Daniels, et al.
Cell Cycle (Georgetown, Tex.)|May 1, 2015
Next generation sequencing demonstrates association between tumor suppressor gene aberrations and poor outcome in patients with cancerMaria Schwaederle, Gregory A Daniels, David E Piccioni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2016
Use of Liquid Biopsies in Clinical Oncology: Pilot Experience in 168 PatientsMaria Schwaederle, Hatim Husain, Paul T Fanta, et al.
Cancer|December 7, 2017
Telomerase reverse transcriptase promoter alterations across cancer types as detected by next-generation sequencing: A clinical and molecular analysis of 423 patientsMaria Schwaederle, Nithya Krishnamurthy, Gregory A Daniels, et al.
Oncotarget|February 6, 2016
Detection rate of actionable mutations in diverse cancers using a biopsy-free (blood) circulating tumor cell DNA assayMaria Schwaederle, Hatim Husain, Paul T Fanta, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Oncotarget|August 7, 2015
Genomic landscape of salivary gland tumorsShumei Kato, Sheryl K Elkin, Maria Schwaederle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2015
Impact of Precision Medicine in Diverse Cancers: A Meta-Analysis of Phase II Clinical TrialsMaria Schwaederle, Melissa Zhao, J Jack Lee, et al.
JAMA Oncology|June 9, 2016
Association of Biomarker-Based Treatment Strategies With Response Rates and Progression-Free Survival in Refractory Malignant Neoplasms: A Meta-analysisMaria Schwaederle, Melissa Zhao, J Jack Lee, et al.
Molecular Cancer Therapeutics|May 20, 2016
Cell-Cycle Gene Alterations in 4,864 Tumors Analyzed by Next-Generation Sequencing: Implications for Targeted TherapeuticsTeresa Helsten, Shumei Kato, Maria Schwaederle, et al.
Molecular Cancer Therapeutics|April 9, 2015
On the Road to Precision Cancer Medicine: Analysis of Genomic Biomarker Actionability in 439 PatientsMaria Schwaederle, Gregory A Daniels, David E Piccioni, et al.
Cell Cycle (Georgetown, Tex.)|February 20, 2015
Cyclin-dependent kinase pathway aberrations in diverse malignancies: clinical and molecular characteristicsShumei Kato, Maria Schwaederle, Gregory A Daniels, et al.
Cell Cycle (Georgetown, Tex.)|May 1, 2015
Next generation sequencing demonstrates association between tumor suppressor gene aberrations and poor outcome in patients with cancerMaria Schwaederle, Gregory A Daniels, David E Piccioni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2016
Use of Liquid Biopsies in Clinical Oncology: Pilot Experience in 168 PatientsMaria Schwaederle, Hatim Husain, Paul T Fanta, et al.
Cancer|December 7, 2017
Telomerase reverse transcriptase promoter alterations across cancer types as detected by next-generation sequencing: A clinical and molecular analysis of 423 patientsMaria Schwaederle, Nithya Krishnamurthy, Gregory A Daniels, et al.
Oncotarget|February 6, 2016
Detection rate of actionable mutations in diverse cancers using a biopsy-free (blood) circulating tumor cell DNA assayMaria Schwaederle, Hatim Husain, Paul T Fanta, et al.
Pageof 3